120 related articles for article (PubMed ID: 578890)
1. Mitotane. Spironolactone antagonism in Cushing's syndrome.
Wortsman J; Soler NG
JAMA; 1977 Dec; 238(23):2527. PubMed ID: 578890
[No Abstract] [Full Text] [Related]
2. [Letter: Idiopathic hemochromatosis and Cushing's disease].
Schrub JC; Courtois H
Nouv Presse Med; 1975 Mar; 4(13):972-3. PubMed ID: 1144042
[No Abstract] [Full Text] [Related]
3. [Neurotoxicity of mitotane therapy of adrenocortical carcinoma (5 cases) and Cushing's syndrome (7 cases)].
du Rostu H; Krempf M; Mussini JM; Murat A; Guillon J; Charbonnel B
Presse Med; 1987 May; 16(19):951-4. PubMed ID: 2954144
[TBL] [Abstract][Full Text] [Related]
4. Mitotane-induced febrile pancytopenia: a first case report in paraneoplastic Cushing's syndrome.
Andrès E; Vinzio S; Goichot B; Schlienger JL
Eur J Endocrinol; 2001 Jan; 144(1):81. PubMed ID: 11174841
[No Abstract] [Full Text] [Related]
5. [Idiopathic intracranial hypertension during treatment of Cushing's disease with mitotane].
Marechaud R; Boissonnot M; Holderer-Fieuzal S; Gouet D; Boissonnot L
Presse Med; 1987 Dec; 16(42):2131. PubMed ID: 2963295
[No Abstract] [Full Text] [Related]
6. [2 cases of Cushing's disease with a hypokalemic alkalosis syndrome].
Guinet P; Mornex R; Revol A; Bertrand J; Veyrat A; Dorsit G
Rev Lyon Med; 1967 Nov; 16(17):696-702. PubMed ID: 5623601
[No Abstract] [Full Text] [Related]
7. Effect of mitotane on Alternaria alternata infection in Cushing's syndrome.
Kasperlik-Zaluska AA; Bieluńska S
Lancet; 1991 Jan; 337(8732):53-4. PubMed ID: 1670675
[No Abstract] [Full Text] [Related]
8. Symptomatic Cushing's syndrome and hyperandrogenemia in a steroid cell ovarian neoplasm: a case report.
Sedhom R; Hu S; Ohri A; Infantino D; Lubitz S
J Med Case Rep; 2016 Oct; 10(1):278. PubMed ID: 27729065
[TBL] [Abstract][Full Text] [Related]
9. [Experiences with Lysodren treatment of Cushing's syndrome in dogs].
Opitz M; Lettow E; Loppnow H; Grevel V
Tierarztl Prax; 1983; 11(4):507-20. PubMed ID: 6658774
[No Abstract] [Full Text] [Related]
10. Adrenal and pituitary effects of mitotane in Cushing's syndrome.
Kasperlik-Załuska A; Jeske W; Migdalska B
Endokrynol Pol; 1986; 37(1):17-21. PubMed ID: 3015579
[No Abstract] [Full Text] [Related]
11. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
[TBL] [Abstract][Full Text] [Related]
12. Cushing's disease.
Trainer PJ; Besser M
Lancet; 2000 Jan; 355(9197):68. PubMed ID: 10615912
[No Abstract] [Full Text] [Related]
13. [Treatment of Cushing's disease with op' DDD].
Golik A; Rosenberg T; Gilboa Y
Harefuah; 1975 Dec; 89(12):563-4. PubMed ID: 1218835
[No Abstract] [Full Text] [Related]
14. [12 years of medical treatment of Cushing's disease. Long-term use of Op, DDD in 46 cases].
Bricaire H; Luton JP
Nouv Presse Med; 1976 Feb; 5(6):325-9. PubMed ID: 1264700
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of Cushing's syndrome with chloditane].
Komissarenko IV
Klin Med (Mosk); 1976 Sep; 54(9):122-7. PubMed ID: 1003908
[No Abstract] [Full Text] [Related]
16. 18 years mitotane therapy for intractable Cushing's disease.
Kawai S; Ichikawa Y; Kaburaki J; Yoshida T
Lancet; 1999 Sep; 354(9182):951. PubMed ID: 10489980
[No Abstract] [Full Text] [Related]
17. [A case of Cushing's disease treated with o,p'-DDD].
Kaneko K; Saito T; Fujioka T; Sugita Y; Takai K
Horumon To Rinsho; 1982 Oct; 30(10):1071-6. PubMed ID: 7165981
[No Abstract] [Full Text] [Related]
18. Treatment of Cushing's disease with o,p'-DDD.
Cooper PR; Shucart WA
N Engl J Med; 1979 Jul; 301(1):48-9. PubMed ID: 449914
[No Abstract] [Full Text] [Related]
19. [The medical treatment of Cushing's syndrome: conclusions drawn from 220 cases].
Bricaire H; Luton JP
Bull Mem Acad R Med Belg; 1978; 133(2 Pt 2):181-92. PubMed ID: 667402
[No Abstract] [Full Text] [Related]
20. [Treatment of Cushing's disease with o, p'-DDD (author's transl)].
Nakagawa K; Ito S; Ohara T; Kubo M; Horikawa H
Horumon To Rinsho; 1981 Sep; 29(9):1135-9. PubMed ID: 7326856
[No Abstract] [Full Text] [Related]
[Next] [New Search]